Sun Pharma stock has gained 5.88 per cent in a year and fallen 2.29 percent in 2023. A total of 0.52 lakh shares of the firm changed hands amounting to a turnover of Rs 5.08 crore on BSE.
"US FDA has directed the Company to take certain corrective actions at the Mohali facility before releasing further final product batches into the US," the company said.